Medical Oncology

, 31:52 | Cite as

Upregulation HOXA10 homeobox gene in endometrial cancer: role in cell cycle regulation

  • Lin Zhang
  • Yicong Wan
  • Yi Jiang
  • Jingjing Ma
  • Jinsong Liu
  • Weiwei Tang
  • Xinru Wang
  • Wenjun ChengEmail author
Original Paper


Homeobox genes encode a group of transcription factors that regulate embryonic development, organ differentiation and cell proliferation. Some researchers found that homeobox gene family could regulate the expression of cell cycle-related factors which are involved in tumorigenesis. The aim of the present study was to determine whether HOXA10 gene could regulate the expression of p21 and control the cell cycle in endometrial cancer. Real-time PCR and Western blot were used to analyze HOXA10 and p21 gene expression in tissue samples of normal endometrium and endometrial cancer. Upregulate and downregulate HOXA10 gene in endometrial cancer cells by HOXA10-vector and HOXA10-siRNA, p21 mRNA and protein expression were tested by real-time PCR and Western blot. FCM analyze the cell cycle alteration, and cell count and EdU assay were recruited to detect cell proliferative activity after upregulation of HOXA10. Expression of HOXA10 and p21 gene decreased in endometrial cancer, and the expression level of HOXA10 was correlated with cancer grade. The percentage of G1 phase cells increased, and cell proliferative activity decreased after upregulate HOXA10 expression. The expression of p16, p27, Myc, Cyclin D1, Cyclin E, CDK2, CDK4 and CDK6 did not alter after upregulation HOXA10. P21 gene mRNA and protein increased/decreased after upregulation/downregulation HOXA10 expression in cancer cells. HOXA10 regulates G1 phase arrest in endometrial cancer which may be mediated by p21.


Endometrial cancer Homeobox gene A10 p21 



Homeobox gene A10


p21waf1/cip1 gene



This work was supported by the National Natural Science Foundation of China (30772332), (81272871), Nature Science Foundation of the Science and Technology Department of Jiangsu Province (BK2010576), Jiangsu Province Six Summit Talent Foundation (303070774IB09) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions [PAPD].

Conflict of interest

The authors declare that they have no competing interests.

Supplementary material

12032_2014_52_MOESM1_ESM.jpg (41 kb)
Supplementary material 1 (JPEG 41 kb)
12032_2014_52_MOESM2_ESM.jpg (162 kb)
Supplementary material 2 (JPEG 162 kb)


  1. 1.
    Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2012;62:10–29.PubMedCrossRefGoogle Scholar
  2. 2.
    McGinnis W, Krumlauf R. Homeobox genes and axial patterning. Cell. 1992;68:283–302.PubMedCrossRefGoogle Scholar
  3. 3.
    Amesse LS, Moulton R, Zhang YM, Pfaff-Amesse T. Expression of HOX gene products in normal and abnormal trophoblastic tissue. Gynecol Oncol. 2003;90:512–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Hsieh-Li HM, Witte DP, Weinstein M, Branford W, Li H, Small K, Potter SS. Hoxa 11 structure, extensive antisense transcription, and function in male and female fertility. Development. 1995;121:1373–85.PubMedGoogle Scholar
  5. 5.
    Benson GV, Lim H, Paria BC, Satokata I, Dey SK, Maas RL. Mechanisms of reduced fertility in Hoxa-10 mutant mice: uterine homeosis and loss of maternal Hoxa-10 expression. Development. 1996;122:2687–96.PubMedGoogle Scholar
  6. 6.
    Li H, Huang CJ, Choo KB. Expression of homeobox genes in cervical cancer. Gynecol Oncol. 2002;84:216–21.PubMedCrossRefGoogle Scholar
  7. 7.
    Bowen NJ, Logani S, Dickerson EB, Kapa LB, Akhtar M, Benigno BB, McDonald JF. Emerging roles for PAX8 in ovarian cancer and endosalpingeal development. Gynecol Oncol. 2007;104:331–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Chu MC, Selam FB, Taylor HS. HOXA10 regulates p53 expression and matrigel invasion in human breast cancer cells. Cancer Biol Ther. 2004;3:568–72.PubMedCrossRefGoogle Scholar
  9. 9.
    Yoshida H, Broaddus R, Cheng W, Xie S, Naora H. Deregulation of the HOXA10 homeobox gene in endometrial carcinoma: role in epithelial-mesenchymal transition. Cancer Res. 2006;66:889–97.PubMedCrossRefGoogle Scholar
  10. 10.
    Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer. 2009;9:153–66.PubMedCrossRefGoogle Scholar
  11. 11.
    Del Bene F, Wittbrodt J. Cell cycle control by homeobox genes in development and disease. Semin Cell Dev Biol. 2005;16:449–60.PubMedCrossRefGoogle Scholar
  12. 12.
    Andreazzoli M, Gestri G, Cremisi F, Casarosa S, Dawid IB, Barsacchi G. Xrx1 controls proliferation and neurogenesis in Xenopus anterior neural plate. Development. 2003;130:5143–54.PubMedCrossRefGoogle Scholar
  13. 13.
    Smith RC, Branellec D, Gorski DH, Guo K, Perlman H, Dedieu JF, Pastore C, Mahfoudi A, Denefle P, Isner JM, Walsh K. p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes Dev. 1997;11:1674–89.PubMedCrossRefGoogle Scholar
  14. 14.
    Bai YQ, Miyake S, Iwai T, Yuasa Y. CDX2, a homeobox transcription factor, upregulates transcription of the p21/WAF1/CIP1 gene. Oncogene. 2003;22:7942–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Taylor HS, Arici A, Olive D, Igarashi P. HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium. J Clin Invest. 1998;101:1379–84.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Toki T, Mori A, Shimizu M, Nikaido T, Fujii S. Localization of apoptotic cells within the human endometrium and correlation between apoptosis and p21 expression. Mol Hum Reprod. 1998;4:1157–64.PubMedCrossRefGoogle Scholar
  17. 17.
    Galderisi U, Jori FP, Giordano A. Cell cycle regulation and neural differentiation. Oncogene. 2003;22:5208–19.PubMedCrossRefGoogle Scholar
  18. 18.
    Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. 2009;9:400–14.PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Liu S, Bishop WR, Liu M. Differential effects of cell cycle regulatory protein p21(WAF1/Cip1) on apoptosis and sensitivity to cancer chemotherapy. Drug Resist Updat. 2003;6:183–95.PubMedCrossRefGoogle Scholar
  20. 20.
    Coller HA, Grandori C, Tamayo P, Colbert T, Lander ES, Eisenman RN, Golub TR. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc Natl Acad Sci USA. 2000;97:3260–5.PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Horiuchi A, Wang C, Kikuchi N, Osada R, Nikaido T, Konishi I. BRCA1 expression is an important biomarker for chemosensitivity: suppression of BRCA1 increases the apoptosis via up-regulation of p53 and p21 during cisplatin treatment in ovarian cancer cells. Biomark Insights. 2007;1:49–59.PubMedCentralPubMedGoogle Scholar
  22. 22.
    Svingen T, Tonissen KF. Hox transcription factors and their elusive mammalian gene targets. Heredity (Edinb). 2006;97:88–96.PubMedCrossRefGoogle Scholar
  23. 23.
    Bromleigh VC, Freedman LP. p21 is a transcriptional target of HOXA10 in differentiating myelomonocytic cells. Genes Dev. 2000;14:2581–6.PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Magnusson M, Brun AC, Miyake N, Larsson J, Ehinger M, Bjornsson JM, Wutz A, Sigvardsson M, Karlsson S. HOXA10 is a critical regulator for hematopoietic stem cells and erythroid/megakaryocyte development. Blood. 2007;109:3687–96.PubMedCrossRefGoogle Scholar
  25. 25.
    Ye L, Mayberry R, Lo CY, Britt KL, Stanley EG, Elefanty AG, Gargett CE. Generation of human female reproductive tract epithelium from human embryonic stem cells. PLoS ONE. 2011;6:e21136.PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Cheng W, Liu J, Yoshida H, Rosen D, Naora H. Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract. Nat Med. 2005;11:531–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B, Jacks T. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 1995;9:935–44.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Lin Zhang
    • 1
  • Yicong Wan
    • 1
  • Yi Jiang
    • 1
  • Jingjing Ma
    • 1
  • Jinsong Liu
    • 2
  • Weiwei Tang
    • 1
  • Xinru Wang
    • 3
  • Wenjun Cheng
    • 1
    • 3
    Email author
  1. 1.The First Affiliated Hospital of Nanjing Medical UniversityNanjingChina
  2. 2.Pathology and Cancer BiologyUniversity of Texas M.D. Anderson Cancer CenterHoustonUSA
  3. 3.State Key Laboratory of Reproductive Medicine, Institution of ToxicologyNanjing Medical UniversityNanjingChina

Personalised recommendations